⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26762607 | 0.83 | NCF1 (0.41) | — | |
| SCHEMBL14396577 | 0.81 | TMEM97 (0.33) | — | |
| SCHEMBL26347919 | 0.79 | KDM4E (0.38) | — | |
| SCHEMBL23603454 | 0.78 | SIGMAR1 (0.38) | — | |
| SCHEMBL26762571 | 0.78 | SIGMAR1 (0.36) | — | |
| SCHEMBL25123178 | 0.75 | HRH3 (0.33) | — | |
| SCHEMBL10202212 | 0.74 | NCF1 (0.43) | — | |
| SCHEMBL21101619 | 0.74 | NCF1 (0.46) | — | |
| SCHEMBL24480749 | 0.73 | NCF1 (0.33) | — | |
| SCHEMBL9036766 | 0.72 | SIGMAR1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365562-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |